Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease

Annals of Neurology

Volumn 49, Issue 4, 2001, Pages 525-529

  Blandini, Fabio ^a,c   Nappi, Giuseppe ^a   Timothy Greenamyre, J ^b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMPLANTATION; INFUSION PUMP; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STRIATONIGRAL DEGENERATION; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; MALE; NERVE DEGENERATION; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0035074475     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.104     Document Type: Article

References (20)

1. Functional changes of the basal ganglia circuitry in Parkinson's disease
2. Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA-L method
3. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey
4. Alternative excitotoxic hypotheses
5. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection
6. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies
7. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid
8. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
9. Association between the low threshold calcium spike and activation of NMDA receptors in guinea-pig substantia nigra pars compacta neurons
10. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
11. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity
12. Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats
13. Improved contrast in histochemical detection of cytochrome oxidase: Metallic ions protocol
14. Glutamate and Parkinson's disease
15. The functional anatomy of basal ganglia disorders
16. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and nonhuman primates: A cytochrome oxidase histochemistry study
17. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibirion via the globus pallidus
18. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat
19. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson' disease
20. Effect of subthalamic nucleus lesion on mirochondrial enzyme activity in rat basal ganglia